Angela S. Dascalescu

Iasi, IS, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy.

Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy.

Journal: Frontiers in pharmacology

Published: November 03, 2025

Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centers.

Real-world patient outcomes with Blinatumomab and Inotuzumab in adult relapsed/refractory B-cell acute lymphoblastic leukemia: a retrospective analysis from two Romanian oncology centers.

Journal: Frontiers in pharmacology

Published: August 12, 2025

Adoptive cellular therapies in non-Hodgkin lymphomas.

Adoptive cellular therapies in non-Hodgkin lymphomas.

Journal: Best practice & research. Clinical haematology

Published: May 13, 2025

Adoptive cellular therapies in multiple myeloma.

Adoptive cellular therapies in multiple myeloma.

Journal: Best practice & research. Clinical haematology

Published: April 23, 2025

Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review.

Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review.

Journal: International journal of molecular sciences

Published: April 01, 2025

Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.

Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience.

Journal: Journal of hematology

Published: September 02, 2024

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response.

Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response.

Journal: Frontiers in medicine

Published: January 20, 2023

Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients.

Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients.

Journal: International journal of molecular sciences

Published: May 20, 2022

A very rare case of FLT3-D835 positive blastic plasmacytoid dendritic cell neoplasm.

A very rare case of FLT3-D835 positive blastic plasmacytoid dendritic cell neoplasm.

Journal: Archive of clinical cases

Published: November 10, 2021

Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma.

Ibrutinib Monotherapy as Bridge-to-Transplant for Relapsed/Refractory Primary Oculo-Cerebral Lymphoma.

Journal: Journal of clinical medicine

Published: August 07, 2021

The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.

The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.

Journal: Immunobiology

Published: June 09, 2020

B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles.

B7-Positive and B7-Negative Acute Myeloid Leukemias Display Distinct T Cell Maturation Profiles, Immune Checkpoint Receptor Expression, and European Leukemia Net Risk Profiles.

Journal: Frontiers in oncology

Published: January 09, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026